Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.62 HKD | -3.12% | -1.59% | -40.95% |
Mar. 28 | Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 18 | Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director | CI |
Sales 2022 | 2.38B 329M 2.57B | Sales 2023 | 2.16B 298M 2.33B | Capitalization | 2.04B 282M 2.21B |
---|---|---|---|---|---|
Net income 2022 | -528M -72.92M -570M | Net income 2023 | -116M -16.02M -125M | EV / Sales 2022 | 2.15 x |
Net Debt 2022 | 2.14B 296M 2.32B | Net Debt 2023 | 867M 120M 936M | EV / Sales 2023 | 1.35 x |
P/E ratio 2022 |
-5.52
x | P/E ratio 2023 |
-6.67
x | Employees | 2,077 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.36% |
1 day | -3.13% | ||
1 week | -1.59% | ||
1 month | +16.98% | ||
3 months | +6.90% | ||
6 months | -45.61% | ||
Current year | -40.95% |
Managers | Title | Age | Since |
---|---|---|---|
Ying Wu
FOU | Founder | 60 | 08-08-26 |
Chen Mao
CEO | Chief Executive Officer | 61 | 08-08-26 |
Wei Xiong
DFI | Director of Finance/CFO | 41 | Nov. 30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiang Rong Li
BRD | Director/Board Member | 51 | 17-12-31 |
- | - | ||
Hai Guang Wang
BRD | Director/Board Member | 60 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.28% | 4 M€ | -27.92% | ||
0.00% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.61% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.62 | -3.13% | 1,386,000 |
24-05-30 | 0.64 | +1.59% | 1,155,000 |
24-05-29 | 0.63 | -3.08% | 1,871,000 |
24-05-28 | 0.65 | +1.56% | 1,583,500 |
24-05-27 | 0.64 | +1.59% | 2,389,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.95% | 170M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 1873 Stock